Smoflipid Injection, Emulsion
Product Images NDC 63323-820

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Smoflipid (NDC 63323-820). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Smo00 0005 01

FDA Label Image

Smo00 0005 02

FDA Label Image

Smo00 0005 03

FDA Label Image

Smo00 0005 04

FDA Label Image

Smo00 0005 05

FDA Label Image

Smo00 0005 06

The text is a table showing the comparison of two oils, soybean oil and SMOFlipid, with regards to their effects on a certain event in a study. The number of subjects with the event and the number censored are provided, as well as the number of patients at risk and study days. There are also graphs at the bottom of the table showing the patients at risk over time for each oil.*

FDA Label Image

Smo00 0005 07

FDA Label Image

Smo00 0005 08

FDA Label Image

Smo00 0005 09

FDA Label Image

Smo00 0005 10

FDA Label Image

Smo00 0005 11

FDA Label Image

Smo00 0005 12

FDA Label Image

Smo00 0005 13

FDA Label Image

Smo00 0005 14

FDA Label Image

Smo00 0005 15

FDA Label Image

Smo00 0005 16

FDA Label Image

Smo00 0005 17

FDA Label Image

Smo00 0005 18

FDA Label Image

Smo00 0005 19

FDA Label Image

Smo00 0005 20

FDA Label Image

Smo00 0005 21

This is a description of a prescription-only intravenous solution contained in a single use sterile container. It contains Soybean Oil, Medium Chain Triglycerides, Olive Oil, Fish Oil, Glycerol, Purified Egg Phospholipids and All-rac-a-Tocopherol, among other ingredients. The energy content of the solution is 200 kcal per 100 mL and it has an adjusted pH level between 6 to 9. The solution should be used only if the package is undamaged and the emulsion is homogenous. Once opened, the solution should be used within 24 hours and any unused portion should be discarded. The container should be protected from freezing and the solution can be stored below 25°C (77°F). The product is manufactured in Uppsala, Sweden, and should not have any additions made to the infusion port. The text also includes a National Drug Code (NDC) number and the manufacturer's reference number for the product.*

FDA Label Image

Smo00 0005 22

This is a description of a medicine in a 100 mL container for intravenous use only, containing soybean oil, USP, medium-chain triglycerides (MCT) NF, olive oil NF, fish oil USP 3g, glycerol USP 2.5g, purified egg phospholipids, NF 1.2g, all-rac-α-tocopherol, USP 0.016 to 0.023g, sodium oleate 0.03g, and water for injection, USP qs. The bag should be undamaged and emulsion homogeneous before use. It should be protected from freezing and must be discarded in case an unused portion left. The medicine is sterile and contains no more than 25 mcg/L of aluminum. It should be stored below 25°C.*

FDA Label Image

Smo00 0005 23

SMOFlipid® is an injectable emulsion lipid solution for intravenous use. It is composed of three types of fats: soybean oil, medium-chain triglycerides, and olive oil, as well as fish oil. It also contains other substances such as glycerol, purified egg phospholipids, all-rac-a-tocopherol, and sodium oleate. The solution is adjusted with sodium hydroxide and water for injection to achieve a pH of 6 to 9 and an osmolarity of 270 mOsm/L. It is important to use the solution within 24 hours after opening and discard any unused portion. The solution is stored below 25°C (77°F) and should not be frozen. It is a sterile single-use container and should not have any additions made to the infusion port. The text also includes the brand name, dose, manufacturer, and NDC code.*

FDA Label Image

Smo00 0005 24

SMOFlipid is an injectable emulsion for intravenous use that has a 20% concentration of Ulipid. It comes in a 500mL bag and is intended for prescription use only. Each 100mL has a combination of soybean oil, medium-chain triglycerides, olive oil, and fish oil, with additional ingredients including glycerol, purified phospholipids, all-rac-a-tocopherol, sodium oleate, and water for injection. The pH is adjusted with sodium hydroxide, and it has an osmolarity of 270 mOsm/L. It contains no more than 25 mcg/L of aluminum and must be used within 24 hours of opening. It is a sterile, single-use container and should not be added to an infusion port. It is manufactured by Fresenius Kabi in Uppsala, Sweden.*

FDA Label Image

Smo00 0005 25

SMOFlipid is a Pharmacy Bulk Package lipid injection emulsion for intravenous use only with energy of 2000 keal per 1000 mL. It contains Soybean Oil, USP, Medium Chain Triglycerides, NF, Olive Oil, NF, Fish Oil, USP, Glycerol, USP, Purified Egg Phospholipids, NF, All-rac-a-Tocopherol, USP, Sodium Oleate, and Water for Injection, USP. It is sold in a 1000mL bag and should not be used for direct infusion. The emulsion must be homogenous and the bag undamaged. Once opened, the content must be used within 4 hours. It must be compounded with other Parenteral Nutrition products. It is sterile and should be stored below 25°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.